Replies to post #222660 on Biotech Values

[Titan V]

A cancer drug that AbbVie acquired in a $10 billion deal is looking more and more like a failure
https://www.businessinsider.com/abbvie-stopped-a-phase-3-trial-after-its-stemcentrx-drug-flopped-2018-12